SHORT BOWEL SYNDROME (SBS)
Clinical trials for SHORT BOWEL SYNDROME (SBS) explained in plain language.
Never miss a new study
Get alerted when new SHORT BOWEL SYNDROME (SBS) trials appear
Sign up with your email to follow new studies for SHORT BOWEL SYNDROME (SBS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a diabetes drug help heal the gut in short bowel syndrome?
Disease control Recruiting nowThis study tests whether a GLP-1 drug (semaglutide) can improve intestinal barrier function in people with short bowel syndrome and intestinal failure. Twenty adults will receive either the drug or a placebo for 28 days, alongside standard care. Researchers will measure blood mar…
Matched conditions: SHORT BOWEL SYNDROME (SBS)
Phase: NA • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated May 17, 2026 03:09 UTC
-
New hope for kids with short bowel: drug may cut need for IV feeding
Disease control Recruiting nowThis study looks at how well the drug teduglutide works in children aged 1 to 17 with short bowel syndrome who rely on IV nutrition. The goal is to see if the drug can reduce the amount of IV nutrition needed or help some children stop it completely. Researchers will review medic…
Matched conditions: SHORT BOWEL SYNDROME (SBS)
Sponsor: Takeda • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Mini-Intestines reveal why a key drug fails some kids
Knowledge-focused Recruiting nowThis study looks at why children with short bowel syndrome respond differently to the drug teduglutide. Researchers will grow tiny, lab-made intestines (organoids) from tissue samples taken during routine surgery. They will then treat these mini-intestines with teduglutide in the…
Matched conditions: SHORT BOWEL SYNDROME (SBS)
Phase: NA • Sponsor: Meyer Children's Hospital IRCCS • Aim: Knowledge-focused
Last updated May 17, 2026 03:12 UTC
-
Do you really know your meds? new study tests GATTEX safety smarts
Knowledge-focused Recruiting nowThis study uses a survey to check how well patients and doctors understand the risks and required monitoring for GATTEX, a medicine for Short Bowel Syndrome. About 600 people (adults who have taken GATTEX recently and their healthcare providers) will answer true/false questions o…
Matched conditions: SHORT BOWEL SYNDROME (SBS)
Sponsor: Takeda • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC